SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-122138
Filing Date
2023-04-27
Accepted
2023-04-27 16:08:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d265889ddefa14a.htm DEFA14A 12072
2 GRAPHIC g265889dsp003.jpg GRAPHIC 285958
3 GRAPHIC g265889dsp004.jpg GRAPHIC 237387
  Complete submission text file 0001193125-23-122138.txt   734127
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36544 | Film No.: 23856876
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences